We build on this by characterizing a molecular mechanism within ECs, whereby the tumor‐induced matrix stiffness increases CCN1 levels, which can modulate β‐catenin signaling and consequently N‐cadherin levels. This evidence concerns the gene CDH2 and neoplasm.